Assessment of Knowledge, Attitude, and Practice among Saudi Residents Regarding Hepatitis E Virus

View More View Less
  • 1 Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Kingdom of Saudi Arabia;
  • | 2 College of Medicine, Palestine Polytechnic University, Hebron, Palestine;
  • | 3 Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif, Kingdom of Saudi Arabia

Global data, including those from Saudi Arabia, that examined public knowledge, attitudes, and practices (KAP) toward hepatitis E virus (HEV) are limited. This study examined KAP levels of the general population in Saudi Arabia toward HEV. A cross-sectional study was conducted among 768 participants. An Arabic electronic questionnaire that contained demographic data and had 35 questions was used to measure KAP of the participants concerning HEV. Collected data were analyzed at a significance level of 0.05. A total of 768 individuals participated in the study, of whom 16.3% (N = 125) were males and 83.7% (N = 643) were females. Study subjects were 18 years and above. Most of the participants were Saudi citizens (95.6%; N = 734), and from Western Saudi Arabia (76.4%; N = 587). Thirty-four percent (N = 261) of the participants had not heard of HEV, and 48% were aware that yellowish skin or eyes are the most important sign of hepatitis. The level of participants’ knowledge about HEV was low (39.5%). However, positive attitudes and practices were apparent and tended to aim at how to avoid becoming infected with HEV. In conclusion, the level of HEV-related knowledge among the participants was low, and their practices and attitudes were aimed at avoiding HEV infection. Awareness campaigns are required to increase the public’s HEV-related knowledge.

Author Notes

Address correspondence to Sayed F. Abdelwahab, Division of Pharmaceutical Microbiology, Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif 21974, Kingdom of Saudi Arabia. E-mail: icpminia@yahoo.com

Authors’ addresses: Shaima O. Althobaiti, Ghaida O. Alhumaidi, Waad M. Alwagdani, Kawther M. Almaroani, and Batool S. Altowairqi, Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Kingdom of Saudi Arabia, E-mails: sheme_8@hotmail.com, ph.ghaida7r@gmail.com, waadbs1@gmail.com, kawther7r7@gmail.com, and albatool-1418@hotmail.com. Mahmoud S. Alhaddad, Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Kingdom of Saudi Arabia, and College of Medicine, Palestine Polytechnic University, Hebron, Palestine, E-mail: dr_mahmoud77@hotmail.com. Sayed F. Abdelwahab, Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif, Kingdom of Saudi Arabia, E-mail: s.fekry@tu.edu.sa.

Save